"I’m determined to make it easier for patients with unmet medical needs and their physicians to find and get access to medicines that are now unavailable to them but could potentially improve their lives.”
Frederik Buijs, Medical Doctor
Meet the team
Who we are
Our team is driven, caring, and determined. Many of us are patients ourselves, so we understand the desire to know about all the available options when diagnosed with a medical condition. While we come from different backgrounds and disciplines, each member of our team contributes expertise that, combined with our technology platform, provides patients and their physicians the keys to drive the necessary change.
Founder & CEO
“I founded myTomorrows to help patients & physicians learn about and find the latest treatments available within Clinical Trials and Early Access Programs.”
Senior Quality Officer
“I believe that patients should be able to get access to other options when they have exhausted regular treatment options. I joined myTomorrows to get medicines that are currently in development to the people in high medical need who want access to them.”
“Working here at myTomorrows, I can go home knowing that what I do at my job means I am helping real people, every day.”
Chief Technology Officer
"As a Computer Scientist, it is very motivating to apply my skills & knowledge directly towards helping patients and physicians navigate the overload of medical data."
Find answers to your questions
What is a Clinical Trial?
When a pharmaceutical or biotechnology company develops a new medicine, they have to test it extensively to evaluate the effects of the medicine on participants’ health and to make sure it is effective and safe enough for public use. Participating in a Clinical Trial can enable patients to be treated with a medicine before it is approved. There is no guarantee that a medicine which is still in clinical development will improve a patient's condition.
Early Access Programs are programs allowed through a special provision in the law that enables treatment with pre-approval medicines of patients with unmet medical needs that suffer from a life-threatening or debilitating disease and which have exhausted treatment options with approved medication.
Different governments, companies and hospitals may use any of these terms to describe programs that provide access to pre-approval medicines:
How is a Clinical Trial different from an Early Access Program?
The purpose of a Clinical Trial is to test a medicine. The purpose of an Early Access Program is to treat patients with an unmet medical need. An unmet medical need in relation to an Early Access Program means for a patient that there is no approved medicine available, or that they have exhausted all approved medicines available.
Clinical trials normally only take place in a limited number of treating centers in a select number of countries. In theory, Early Access Programs can help patients anywhere.
Why do I need my doctor’s support for an Early Access Program?
You need your doctor’s support because you will not only need a prescription for the medicine, but your treating doctor understands your full health history and needs. Your doctor also ensures that the pre-approval medicine you would like to be treated with is suitable, can inform you about how the medicine works, and possible risks and side effects.
Can myTomorrows help arrange reimbursement for the medicine?
Yes, myTomorrows can help to arrange reimbursement for the cost of the medicine. We know from experience how reimbursement systems in many countries work, so we’re ready and able to facilitate this. This often happens on a case-by-case basis. To find out how reimbursement works in your country please contact us.